Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogs

Documents similaires

• Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
  par: Costa VP, et autres
  Publié: (2012)
• Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
  par: Kozobolis V, et autres
  Publié: (2018)
• Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
  par: Schnober D, et autres
  Publié: (2015)
• A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
  par: Douglas J Rhee, et autres
  Publié: (2008)
• First experience with BAK-free travoprost 0.004% in topical glaucoma medication
  par: Gado AS, et autres
  Publié: (2011)